Injectable Artesunate Tools & Training
WHO recommends parenteral artesunate in preference to quinine and artemether for the treatment of severe P. falciparum malaria in adults and children. Intravenous (IV) injection is the preferred route of administration although intramuscular (IM) injection is also possible. To ensure that healthcare providers fully understand how to prepare and administer the product, these training materials were developed to illustrate these steps and facilitate correct use of the product.
65 health workers across 7 institutions in Kenya were interviewed to test these materials and to ensure they were well understood. New versions that incorporated lessons learned were tested daily in-situ over two weeks, to ensure that the final training materials better meet the needs of health personnel who treat patients with severe malaria. This project was carried out with continuous feedback from WHO GMP (Global Malaria Programme), MSF, Swiss TPH, PMI, MMV and CHAI.